DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Benedict Chambers

CEO

Prodessa Pharmaceuticals

Stockholm, Sweden

43 profile visitsSpeakerAcademia / TTO / Emerging Companies / Public Research Organisation / Non-profit Oganisation

My organisation

Prodessa Pharmaceuticals is a Stockholm-based animal health company, founded in 2025 by researchers from the Karolinska Institutet, Sweden, and SUNY Upstate New York, USA. We are driven by our mission, that through dedication, innovation and cutting-edge research, be on the frontier in the fight against pet obesity. Our flagship molecule, K161, a pan-SHIP1/2 inhibitor, reduces chronic inflammation and improves oxidative metabolism to promote leanness and preserve muscle mass. In preclinical small animal trials, K161 achieved a 20–25% weight reduction without appetite suppression, change in diet or enhanced physical activity. We are now looking for partners to join our journey.
Read more

About me

Social media

Additional questions

Interests

Pharmaceutical / TherapeuticsCompanion animals

Speaker sessions (1)

Thursday, 21 May 2026

09:00 - 10:30

Innovation Spotlight - Emerging Start-ups

Location:BMCC - 1st Floor - AuditoriumTrack:Pitch Session

The Emerging Start-ups session is designed for entrepreneurial scientists preparing to launch start-ups that address unmet needs in animal health and welfare through innovative technologies.